Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 7, 2016

Primary Completion Date

January 6, 2017

Study Completion Date

March 27, 2017

Conditions

Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women

Interventions

DRUG

Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL)

DRUG

Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL)

Trial Locations (1)

Lotus Clinical Research, LLC, Pasadena